Consensus Paradigm Biopharmaceuticals Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:31 2024-05-06 am EDT			5-day change	1st Jan Change
0.235 ^AUD	-4.08%		-12.96%	-44.71%

Apr. 19	Paradigm Biopharmaceuticals Submits Documents to FDA for Phase 3 Osteoarthritis Program	MT
Feb. 28	Paradigm Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

606b0de.xmTcuxeF2XdcUnY5NPhfgtndZfhaK0Xj2wXm6xzXCAc.iSXlynzIjAUqHgB3XsFvy-vvHZYWeCGLsEuJg3KScTT_A6_TfPS3OgsHMw~f3acd0f3fc1a13c78010363c8bef32dd

Lingering Concerns on Economic Outlook, Rate Hikes Dampen Appetite for Australian Shares	22-12-28	MT
Australian Shares Rise to One-Month High After US Fed Rate Hike	22-03-17	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.235 AUD

Average target price

2.295 AUD

Spread / Average Target

+876.60%

High Price Target

3.19 AUD

Spread / Highest target

+1,257.45%

Low Price Target

1.4 AUD

Spread / Lowest Target

+495.74%